| Authors: |
Hamid O; The Angeles Clinic and Research Institute, Los Angeles, California. ohamid@theangelesclinic.org., Molinero L; Genentech, Inc., South San Francisco, California., Bolen CR; Genentech, Inc., South San Francisco, California., Sosman JA; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee., Muñoz-Couselo E; Vall d'Hebrón University Hospital and Vall d'Hebrón Institute of Oncology, Barcelona, Spain., Kluger HM; Yale University School of Medicine and Yale Cancer Center, New Haven, Connecticut., McDermott DF; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Powderly JD; Carolina BioOncology Institute, Huntersville, North Carolina., Sarkar I; Genentech, Inc., South San Francisco, California., Ballinger M; Genentech, Inc., South San Francisco, California., Fassò M; Genentech, Inc., South San Francisco, California., O'Hear C; Genentech, Inc., South San Francisco, California., Chen DS; Genentech, Inc., South San Francisco, California., Hegde PS; Genentech, Inc., South San Francisco, California., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. |
